Ausgabe 6/2022
Inhalt (22 Artikel)
Alterations of sodium-hydrogen exchanger 1 function in response to SGLT2 inhibitors: what is the evidence?
Surasak Wichaiyo, Nakkawee Saengklub
Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure
Filippos Triposkiadis, Andrew Xanthopoulos, John Skoularigis, Randall C. Starling
The cardiosplenic axis: the prognostic role of the spleen in heart failure
Hiroaki Hiraiwa, Takahiro Okumura, Toyoaki Murohara
Myocarditis following COVID-19 vaccination in adolescents and adults: a cumulative experience of 2021
Onyedika J. Ilonze, Maya E. Guglin
Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging
Georgios M. Alexandridis, Efstathios D. Pagourelias, Nikolaos Fragakis, Maria Kyriazi, Efthymia Vargiami, Dimitrios Zafeiriou, Vassilios P. Vassilikos
Cardiovascular disease associated with methamphetamine use: a review
Jared Tobolski, Douglas B. Sawyer, Sharon J. Song, Maxwell Eyram Afari
Predictors of fatal arrhythmic events in patients with non-compaction cardiomyopathy: a systematic review
George Bazoukis, Konstantinos Tyrovolas, Konstantinos P. Letsas, Konstantinos Vlachos, Danny Radford, Cheuk To Chung, Tong Liu, Michael Efremidis, Gary Tse, Adrian Baranchuk
Ambulatory factors influencing pulmonary artery pressure waveforms and implications for clinical practice
Amit Alam, Rita Jermyn, Ioannis Mastoris, Leslie Steinkamp, Arvind Bhimaraj, Andrew J. Sauer
The role of cardiac magnetic resonance in identifying appropriate candidates for cardiac resynchronization therapy — a systematic review of the literature
George Bazoukis, Jeremy Man Ho Hui, Yan Hiu Athena Lee, Oscar Hou In Chou, Dimitrios Sfairopoulos, Konstantinos Vlachos, Athanasios Saplaouras, Konstantinos P. Letsas, Michael Efremidis, Gary Tse, Vassilios S. Vassiliou, Panagiotis Korantzopoulos
Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition
Antonis S. Manolis, Theodora A. Manolis, Antonis A. Manolis, Helen Melita
Cardiorenal syndrome: long road between kidney and heart
Carolina Victoria Cruz Junho, Mayra Trentin-Sonoda, Karine Panico, Raquel Silva Neres dos Santos, Mariana Vieira Abrahão, Imara Caridad Stable Vernier, Cristina Ribas Fürstenau, Marcela Sorelli Carneiro-Ramos
Soluble ST2: a valuable prognostic marker in heart failure
Sugeevan Savarimuthu, Pavan Goel, Amer Harky
Association between electrical and mechanical remodeling after cardiac resynchronization therapy: systematic review and meta-analysis of observational studies
David Pilecky, Gabor Z. Duray, Dietmar Elsner, Carsten W. Israel, Julia W. Erath-Honold, Mate Vamos
Is it time to revisit ICD indications?
Amin Yehya, Jonathan D. Davis, Andrew J. Sauer, Nasrien E. Ibrahim
Discussion of LBBP synchronization effects in HF patients with LBBB and comparison with BiV-CRT
Shigeng Zhang, Qijun Shan
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis
Paolo Morfino, Alberto Aimo, Giorgia Panichella, Claudio Rapezzi, Michele Emdin
Outcomes of heart transplantation in cardiac amyloidosis: an updated systematic review
Sofia Lakhdar, Chandan Buttar, Mahmood Nassar, Camelia Ciobanu, Rima Patel, Most Sirajum Munira
MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers
Fanyan Luo, Wei Liu, Haisong Bu
The heart and gut relationship: a systematic review of the evaluation of the microbiome and trimethylamine-N-oxide (TMAO) in heart failure
Kelley M. Anderson, Erin P. Ferranti, Emily Couvillon Alagha, Emma Mykityshyn, Casey E. French, Carolyn Miller Reilly
Follistatin-like 1 and its paralogs in heart development and cardiovascular disease
Martin Horak, DeLisa Fairweather, Piia Kokkonen, David Bednar, Julie Bienertova-Vasku